LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc., a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is ...
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results